GlassScriptPhysician profile
Robin Nussbaum Phillips
NPI 1306938378
$2,269.86
in general payments reported to CMS, 2019-2025
20 companies · $171 in 2025
The $171 reported for 2025 was more than what a typical Gynecology provider received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,265 · 2020: $263 · 2021: $152 · 2022: $205 · 2023: $125 · 2024: $89.36 · 2025: $171.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $372 · Education: $13.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $371.62 |
| Education | $13.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $365.57 | 2019-2021 | |
| Lilly USA, LLC | $350.49 | 2019-2025 | Zepbound |
| Vertical Pharmaceuticals, LLC | $279.58 | 2019 | |
| Astellas Pharma US INC | $231.34 | 2019-2023 | Veozah |
| Therapeuticsmd, INC. | $228.48 | 2019-2021 | |
| Aspira Women'S Health INC | $118.50 | 2022 | |
| Millicent US INC | $114.56 | 2019-2025 | Intrarosa |
| Amgen INC. | $110.55 | 2020-2022 | |
| Amag Pharmaceuticals, INC. | $59.18 | 2019 | |
| Ascend Therapeutics US, LLC | $57.97 | 2019-2022 | |
| Amarin Pharma, INC. | $57.02 | 2019 | |
| Aytu Biopharma, INC. | $50.29 | 2019 | |
| Corcept Therapeutics | $48.62 | 2019-2020 | |
| Pfizer INC. | $46.99 | 2019-2024 | |
| Exeltis, USA INC. | $42.11 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $35.15 | 2019 | |
| Ibsa Pharma INC. | $21.48 | 2019 | |
| Acerus Pharmaceuticals Corporation | $17.83 | 2021 | |
| Mannkind Corporation | $17.65 | 2019 | |
| Avion Pharmaceuticals | $16.50 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robin Phillips listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.